Urinary angiotensinogen as a biomarker for acute to chronic kidney injury transition - prognostic and mechanistic

Katie L Connor1, Laura Denby2

  • 1Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K.

Insights

Urinary angiotensinogen (uAGT) may predict acute kidney injury (AKI) progression to chronic kidney disease (CKD). This biomarker could indicate renal recovery potential, guiding targeted interventions for kidney disease patients.

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Renal Medicine

Background:

  • Accurate biomarkers for predicting chronic kidney disease (CKD) progression and early detection are currently lacking.
  • This deficiency hinders the identification of individuals who could benefit from timely therapeutic interventions.
  • Urinary angiotensinogen (uAGT) is investigated as a potential predictive biomarker for kidney disease progression.

Purpose of the Study:

  • To evaluate the predictive capability of urinary angiotensinogen (uAGT) in forecasting the transition from acute kidney injury (AKI) to chronic kidney disease (CKD).
  • To assess uAGT as a dynamic marker of renal injury and its potential to predict structural recovery post-AKI.
  • To explore the clinical utility of uAGT and the potential of early renin-angiotensin system blockade as a therapeutic strategy following AKI.

Main Methods:

  • Utilized a murine model of ischemia-reperfusion injury to investigate uAGT's predictive potential.
  • Analyzed data from a small prospective study involving patients with biopsy-proven acute tubular necrosis.
  • Correlated uAGT levels with the progression of kidney injury and recovery outcomes.

Main Results:

  • Findings suggest uAGT serves as a dynamic indicator of renal injury.
  • uAGT may predict the likelihood of structural recovery after acute kidney injury.
  • The study provides preliminary evidence for uAGT's role in AKI-to-CKD transition prediction.

Conclusions:

  • Urinary angiotensinogen (uAGT) shows promise as a biomarker for predicting AKI to CKD progression.
  • uAGT may offer insights into renal recovery potential following AKI.
  • Further research is warranted to establish the clinical utility of uAGT and explore renin-angiotensin system blockade as a therapeutic target in AKI recovery.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
717
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
451
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
355
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
932
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
333